Saxenda Samples: Coupons, Savings Card & 2026 Alternatives
Saxenda is Novo Nordisk's liraglutide product for chronic weight management — the first-generation GLP-1 agonist that pre-dated Wegovy by almost a decade. It's a daily injection, not weekly, which is the feature that most shapes both its clinical position and its pricing in 2026.
Saxenda sample searches are a different animal than Ozempic or Wegovy searches. The market has largely moved past liraglutide toward semaglutide and tirzepatide, so manufacturer programs are less aggressive and third-party telehealth providers carry it less often. The patients who still search for Saxenda typically have a specific reason — tolerance to newer GLP-1s, insurance formulary restrictions, or a clinician's judgment call about daily vs. weekly dosing.
This guide covers what Saxenda actually costs in 2026, why it's often the wrong first choice, and when it's genuinely the right answer for specific patients.
What's actually available: Saxenda samples in 2026
Three paths for people typing “saxendasamples” — what they actually mean, typical cost, and who each path fits.
| Path | What it actually is | Typical cost | Best for |
|---|---|---|---|
| Saxenda savings card | Novo Nordisk copay assistance for commercially insured patients. | ~$200 off / month, minimum $25 copay | Commercially insured patients whose plan prefers liraglutide |
| Generic liraglutide (post-2025) | FDA-approved generic liraglutide, available at retail pharmacies. | $350–$650 / month cash | Cash-pay patients who specifically want liraglutide |
| Retail brand Saxenda | Brand-name Saxenda without any manufacturer assistance. | ~$1,349 / month | Rarely optimal — usually the savings card or generic beats this |
How Saxenda sample programs actually work
Why Saxenda lost market share to Wegovy
Saxenda (liraglutide) was the first daily-injection GLP-1 approved for chronic weight management, in 2014. Wegovy (semaglutide) superseded it in 2021 with a weekly injection and larger mean weight loss in trials. By 2024, most clinicians defaulted to Wegovy as first-line GLP-1 therapy for obesity, using Saxenda when a patient couldn't tolerate semaglutide or when insurance formularies specifically required liraglutide first.
What generic liraglutide changed in 2025
FDA approved the first generic liraglutide in 2024, and it reached retail pharmacies in 2025. Generic pricing sits at $350–$650 per month cash — still expensive relative to compounded semaglutide, but meaningfully below brand Saxenda's $1,349 retail price. Insurance formularies now often prefer the generic over brand Saxenda, which can actually complicate the savings card math: patients with coverage for the generic may find the brand savings card less valuable than the generic cash price.
When Saxenda is the right clinical choice
Clinicians specifically prefer liraglutide in a few scenarios: patients with severe GI intolerance to weekly semaglutide or tirzepatide; patients with specific cardiovascular histories where clinicians value liraglutide's LEADER trial cardiovascular outcomes data; and patients transitioning from the 3.0 mg obesity dose of liraglutide in a long-established treatment plan. For most new-start weight-management patients, newer weekly GLP-1s are a better first choice.
Saxenda isn't obsolete — it's simply the second choice for a category that got better. The patients it fits are the ones newer GLP-1s don't.
Top providers offering Saxenda or the compounded alternative
Providers we've verified currently support a clinically appropriate Saxenda path. Pricing and availability vary by state. Every link is an affiliate link tracked through Impact Engine — see our disclosure.
| Rank | Provider | Best for | Sample type | Editor | Readers | Action |
|---|---|---|---|---|---|---|
| #1 | Sesame Care Semaglutide · Tirzepatide | best-for-one-time-visit | telehealth | 4.2 / 5 | — | See offer |
| #2 | Hims Weight Loss Compounded Semaglutide · Liraglutide | best-for-brand-name | telehealth | 4.1 / 5 | — | See offer |
Sesame Care
A la carte telehealth where you pay per visit and get real GLP-1 prescriptions at list pricing.
- ✓ No subscription or recurring fee
- ✓ Pay once for the consult
- ✓ Use your own pharmacy + GoodRx
- − Medication cost is separate
- − No built-in coaching or support
- − Availability varies by state
Hims Weight Loss
National telehealth brand with an oral-and-injectable weight-loss lineup.
- ✓ Bundled flat pricing
- ✓ Major national brand
- ✓ Both oral and injectable options
- − Clinical customization limited vs. peers
- − Compounded only (no branded Rx)
- − Higher churn on 12-month subscriptions
Saxenda cost in 2026: every legitimate price path
What you'll actually pay depends on insurance, the path you take, and whether you stay on the brand-name drug. Here's the real money:
| Path | First month | Ongoing | Notes |
|---|---|---|---|
| Saxenda savings card (commercial) | $25 (best case) to $400 (covered plan) | Same | Card covers up to $200/mo; remaining copay varies by plan. |
| Generic liraglutide cash | $350–$650 | Same | FDA-approved 2024; retail availability through 2025. |
| Retail brand Saxenda cash | ~$1,349 | Same | Uncommon path in 2026; generic almost always cheaper. |
What to expect on Saxenda: your first weeks
Saxenda titration runs over 5 weeks: 0.6 mg daily for 7 days, then up by 0.6 mg each week to the 3.0 mg maintenance dose. That's a different cadence from the monthly titrations of Wegovy and Zepbound — faster to reach maintenance, but with more concentrated side-effect burden in weeks one and two.
GI side effects are qualitatively similar to other GLP-1s: nausea, constipation, occasional reflux. The daily dosing means side effects recur daily, which some patients find worse than weekly dosing's cadence.
Response data in trials showed 8.0% mean weight loss at 56 weeks, versus Wegovy's 14.9% at 68 weeks. This isn't a pure comparison — different trial designs — but the directional gap is real and informs the clinical preference for newer GLP-1s.
Clinical evidence behind Saxenda
Saxenda (liraglutide 3.0 mg) was FDA-approved in December 2014 based on the SCALE trial program. SCALE Obesity and Prediabetes showed 8.0% mean body weight reduction at 56 weeks compared to 2.6% on placebo. LEADER (2016) established liraglutide's cardiovascular benefit in diabetes patients, which has informed some clinicians' preference for liraglutide in patients with significant cardiovascular risk.
Saxendaside effects & who shouldn't take it
This is not medical advice. Discuss every medication decision with a licensed clinician who knows your full medical history.
Common side effects
- •Nausea (common, daily recurrence)
- •Diarrhea or constipation
- •Vomiting in the first two weeks
- •Fatigue during titration
- •Injection-site reactions (daily injections amplify cumulative exposure)
- •Rare but serious: pancreatitis, gallbladder disease, MTC boxed warning
Who shouldn't take Saxenda
- •Personal or family history of medullary thyroid carcinoma
- •Multiple endocrine neoplasia syndrome type 2
- •Pregnancy or planned pregnancy within 2 months
- •Severe pancreatitis history
- •Eating disorder not in remission
Eligibility for Saxenda
- •Adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity
- •Willingness to inject daily (vs. weekly for Wegovy/Zepbound)
- •Commercial insurance for full savings card value
- •Not required: prior-drug failure, though some plans prefer Saxenda after a generic step
Saxenda samples: frequently asked
Are Saxenda samples actually free?
Novo Nordisk does not distribute consumer-facing free Saxenda samples. The savings card is the primary consumer-accessible assistance, with up to $200 off per month for eligible commercially insured patients.
How much is Saxenda without insurance?
Brand Saxenda retails around $1,349 per month. Generic liraglutide (approved 2024, widely available 2025) is $350–$650 per month cash and is usually the cheaper path.
Is Saxenda better than Wegovy?
In trial outcomes, Wegovy showed larger mean weight loss (14.9% vs. 8.0%). Saxenda may be preferred for specific patients based on clinical history, insurance formulary, or tolerance — but for most new patients, newer weekly GLP-1s are the better first choice.
Can I switch from Saxenda to Wegovy or Zepbound?
Yes, with a new prescription. Clinicians typically transition with a one-week washout, then start the new drug at its lowest titration dose.
Is there a generic version of Saxenda?
Yes — FDA approved the first generic liraglutide in 2024, and it reached retail pharmacies in 2025. It carries the same clinical effect as brand Saxenda at a lower cash price.
Does insurance cover Saxenda?
Commercial coverage varies. Some plans prefer generic liraglutide; others still cover brand Saxenda. Medicare Part D does not cover weight-loss drugs (including Saxenda) by statute.
What BMI do I need for Saxenda?
BMI ≥30 qualifies alone, or BMI ≥27 with at least one weight-related comorbidity such as hypertension, dyslipidemia, Type 2 diabetes, or obstructive sleep apnea.
Is Saxenda the same as Victoza?
Same active ingredient (liraglutide), different FDA labels and doses. Saxenda is 3.0 mg for weight management. Victoza is 1.8 mg for Type 2 diabetes.